Rac-11-Deoxy-8(12)-dehydro Misoprostol is a synthetic analog of prostaglandin E1, primarily used for its pharmacological effects in the treatment of gastrointestinal disorders, particularly in preventing gastric ulcers associated with nonsteroidal anti-inflammatory drugs (NSAIDs). This compound exhibits characteristics typical of prostaglandins, including the ability to induce smooth muscle contraction and modulate inflammatory responses. Its structure features a modified prostaglandin backbone, which contributes to its biological activity and stability. The racemic nature of this compound indicates the presence of two enantiomers, which may exhibit different pharmacological properties. In terms of solubility, it is generally lipophilic, allowing for effective absorption in biological systems. The compound's mechanism of action involves binding to specific prostaglandin receptors, leading to various physiological effects, including cytoprotection of the gastric mucosa. Safety and efficacy profiles are established through clinical studies, and it is essential to consider potential side effects, such as gastrointestinal disturbances, when using this medication. Overall, rac-11-Deoxy-8(12)-dehydro Misoprostol represents a significant advancement in therapeutic options for managing gastric health.

rac-11-Deoxy-8(12)-dehydro Misoprostol

1331639-92-9: Rac-11-Deoxy-8(12)-dehydro Misoprostol is a synthetic analog of prostaglandin E1, primarily used for its pharmacological effects in the treatment of gastrointestinal disorders, particularly in preventing gastric ulcers associated with nonsteroidal anti-inflammatory drugs (NSAIDs). This compound exhibits characteristics typical of prostaglandins, including the ability to induce smooth muscle contraction and modulate inflammatory responses. Its structure features a modified prostaglandin backbone, which contributes to its biological activity and stability. The racemic nature of this compound indicates the presence of two enantiomers, which may exhibit different pharmacological properties. In terms of solubility, it is generally lipophilic, allowing for effective absorption in biological systems. The compound's mechanism of action involves binding to specific prostaglandin receptors, leading to various physiological effects, including cytoprotection of the gastric mucosa. Safety and efficacy profiles are established through clinical studies, and it is essential to consider potential side effects, such as gastrointestinal disturbances, when using this medication. Overall, rac-11-Deoxy-8(12)-dehydro Misoprostol represents a significant advancement in therapeutic options for managing gastric health.

CAS 1331639-92-9

rac-11-Deoxy-8(12)-dehydro Misoprostol

rac-11-Deoxy-8(12)-dehydro Misoprostol

Ref: TR-D232630